These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2353985)

  • 21. Preliminary evaluation of myocardial toxicity of 4'-deoxydoxorubicin: experimental and clinical results.
    Villani F; Comazzi R; Genitoni V; Lacaita G; Guindani A; Crippa F; Monti E; Piccinini F; Rozza A; Lanza E
    Drugs Exp Clin Res; 1985; 11(3):223-31. PubMed ID: 3836127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The prevention of the myocardial toxicity of doxorubicin with superoxide dismutase].
    Villani F; Galimberti M; Favalli L; Rozza A; Lanza E; Poggi P
    G Ital Cardiol; 1991 Jun; 21(6):633-41. PubMed ID: 1743445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of doxorubicin and doxorubicin-3-ol in rat heart.
    Rossini L; Monti E; Cova D; Piccinini F
    Arch Toxicol Suppl; 1986; 9():474-8. PubMed ID: 3468931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distribution characteristics of carboxymethylpullulan-peptide-doxorubicin conjugates in tumor-bearing rats: different sequence of peptide spacers and doxorubicin contents.
    Nogusa H; Yamamoto K; Yano T; Kajiki M; Hamana H; Okuno S
    Biol Pharm Bull; 2000 May; 23(5):621-6. PubMed ID: 10823676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Doxorubicin cardiotoxicity: contractile changes after long-term treatment in the rat.
    Jensen RA
    J Pharmacol Exp Ther; 1986 Jan; 236(1):197-203. PubMed ID: 3941392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabonomic identification of novel biomarkers in doxorubicin cardiotoxicity and protective effect of the natural antioxidant oleuropein.
    Andreadou I; Papaefthimiou M; Zira A; Constantinou M; Sigala F; Skaltsounis AL; Tsantili-Kakoulidou A; Iliodromitis EK; Kremastinos DT; Mikros E
    NMR Biomed; 2009 Jul; 22(6):585-92. PubMed ID: 19308947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Doxorubicin cardiotoxicity in the rat: comparison of electrocardiogram, transmembrane potential, and structural effects.
    Jensen RA; Acton EM; Peters JH
    J Cardiovasc Pharmacol; 1984; 6(1):186-200. PubMed ID: 6199603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of serum levels of cardiac troponin T to compare the protective activity of dexrazoxane against doxorubicin- and mitoxantrone-induced cardiotoxicity.
    Herman EH; Zhang J; Rifai N; Lipshultz SE; Hasinoff BB; Chadwick DP; Knapton A; Chai J; Ferrans VJ
    Cancer Chemother Pharmacol; 2001 Oct; 48(4):297-304. PubMed ID: 11710630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effects of caffeic acid phenethyl ester on doxorubicin-induced cardiotoxicity in rats.
    Fadillioglu E; Oztas E; Erdogan H; Yagmurca M; Sogut S; Ucar M; Irmak MK
    J Appl Toxicol; 2004; 24(1):47-52. PubMed ID: 14745846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats.
    Saad SY; Najjar TA; Al-Rikabi AC
    Pharmacol Res; 2001 Mar; 43(3):211-8. PubMed ID: 11401411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute doxorubicin cardiotoxicity is successfully treated with the phytochemical oleuropein through suppression of oxidative and nitrosative stress.
    Andreadou I; Sigala F; Iliodromitis EK; Papaefthimiou M; Sigalas C; Aligiannis N; Savvari P; Gorgoulis V; Papalabros E; Kremastinos DT
    J Mol Cell Cardiol; 2007 Mar; 42(3):549-58. PubMed ID: 17223128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melatonin improves cardiac and mitochondrial function during doxorubicin-induced cardiotoxicity: A possible role for peroxisome proliferator-activated receptor gamma coactivator 1-alpha and sirtuin activity?
    Govender J; Loos B; Marais E; Engelbrecht AM
    Toxicol Appl Pharmacol; 2018 Nov; 358():86-101. PubMed ID: 29966675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiotoxicity and antitumor activity of a copper(II)-doxorubicin chelate.
    Monti E; Paracchini L; Piccinini F; Malatesta V; Morazzoni F; Supino R
    Cancer Chemother Pharmacol; 1990; 25(5):333-6. PubMed ID: 2155062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of lipid composition on the antitumor activity exerted by doxorubicin-containing liposomes in a rat solid tumor model.
    Storm G; Roerdink FH; Steerenberg PA; de Jong WH; Crommelin DJ
    Cancer Res; 1987 Jul; 47(13):3366-72. PubMed ID: 3581073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of doxorubicin-induced cardiotoxicity by recombinant interleukin-1 in hamsters. Doxorubicin cardiotoxicity and interleukin-1.
    Yoshida T; Okumura H; Kaya H; Okabe Y; Matano S; Ohtake S; Nakamura S; Matsuda T
    Biotherapy; 1993; 6(2):125-32. PubMed ID: 8398571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardioprotective roles of aged garlic extract, grape seed proanthocyanidin, and hazelnut on doxorubicin-induced cardiotoxicity.
    Demirkaya E; Avci A; Kesik V; Karslioglu Y; Oztas E; Kismet E; Gokcay E; Durak I; Koseoglu V
    Can J Physiol Pharmacol; 2009 Aug; 87(8):633-40. PubMed ID: 19767888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective effect of CardiPro against doxorubicin-induced cardiotoxicity in mice.
    Mohan IK; Kumar KV; Naidu MU; Khan M; Sundaram C
    Phytomedicine; 2006 Mar; 13(4):222-9. PubMed ID: 16492523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-term and long-term models of doxorubicin-induced cardiomyopathy in rats: A comparison of functional and histopathological changes.
    O'Connell JL; Romano MM; Campos Pulici EC; Carvalho EE; de Souza FR; Tanaka DM; Maciel BC; Salgado HC; Fazan-Júnior R; Rossi MA; Simões MV
    Exp Toxicol Pathol; 2017 Apr; 69(4):213-219. PubMed ID: 28153388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of the antitumor activity and toxicity of long-circulating and fusogenic liposomes co-encapsulating paclitaxel and doxorubicin in a murine breast cancer animal model.
    Franco MS; Roque MC; de Barros ALB; de Oliveira Silva J; Cassali GD; Oliveira MC
    Biomed Pharmacother; 2019 Jan; 109():1728-1739. PubMed ID: 30551427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amelioration of Doxorubicin-Induced Cardiac and Renal Toxicity by Oxycarotenoid Lutein and Its Mechanism of Action.
    Sindhu ER; Nithya TR; Binitha PP; Kuttan R
    J Environ Pathol Toxicol Oncol; 2016; 35(3):237-247. PubMed ID: 27910779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.